The DOI matches its Crossref record; 103 of the 107 references it cites were found in a registry or an index.
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases
Abstract
Matrix metalloproteinases (MMPs) and proteins containing a disintegrin and metalloproteinase domain (ADAM) are important in neuroinflammation, and recent studies have linked their actions to neurodegenerative disorders. MMPs act as cell-surface sheddases and can affect cell signalling initiated by growth factors or death receptors. Four tissue inhibitors of metalloproteinases (TIMPs) regulate metalloproteinase activity. These proteases increase the permeability of the blood-brain barrier, which can cause oedema, haemorrhage, and cell death. MMPs also participate in tissue repair by promoting angiogenesis and neurogenesis. In vascular cognitive impairment, MMPs change permeability of the blood-brain barrier and might contribute to white matter damage. MMPs and ADAMs might contribute to the formation and degradation of amyloid proteins in Alzheimer's disease and cause death of dopaminergic neurons in Parkinson's disease. In this Review, by examining the effects of neuroinflammation, we try to understand the role that MMPs might have in neurodegenerative diseases. Therapeutic strategies that use inhibitors of MMPs could represent potential novel treatments for neurological diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Adam17 and Arg2 proteins affect Hif-1α stability and activity by regulating production of tumor necrosis factor α (TNF-α) 31,32 and nitric oxide, respectively 33,34 , whereas Mmp3 has key roles in numerous physiological processes 35 .”
From The yak genome and adaptation to life at high altitude (2012) · cites this paper as [35]
Citations
Cites
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942
Tissue inhibitors of metalloproteinases: evolution, structure and function
Brew, K., Dinakarpandian, D., & Nagase, H. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00279-4 · Cited by 1,932
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1106 · Cited by 1,808
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I. E., Bannikov, G. A., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,589
Van Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease
Girouard, H., & Iadecola, C. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00966.2005 · Cited by 1,311
VEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain
Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. V., & Chopp, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9369 · Cited by 1,296
Cited by
Sorted by citations
Items 201–300 of 598
Maysinger, D., Ji, J. X., Hutter, E., & COOPER, E. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00480 · Cited by 45
Chen, S., Cui, J., Jiang, T., Olson, E. S., Cai, Q.-Y., Yang, M., Wu, W., Guthrie, J. M., Robertson, J. D., Lipton, S. A., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15621573 · Cited by 44
Iulita, M. F., Ganesh, A., Pentz, R., Aguilar, L. F., Gubert, P., Ducatenzeiler, A., Christie, S., Wilcock, G. K., & Cuello, A. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180970 · Cited by 45
Neuroprotective potential of isothiocyanates in an in vitro model of neuroinflammation
Latronico, T., Larocca, M., Milella, S., Fasano, A., Rossano, R., & Liuzzi, G. M. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00772-w · Cited by 43
Cirillo, G., Pepe, R., Siciliano, M., Ippolito, D., Ricciardi, D., Stefano, M. D., Buonanno, D., Atripaldi, D., Abbadessa, S., Perfetto, B., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043231 · Cited by 42
Peng, K., Zhang, Y., Liu, D.-Y., & Chen, J. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02862-5 · Cited by 42
Liu, H., & Shubayev, V. I. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.06.015 · Cited by 44
Critical role of calpain in spinal cord degeneration in P arkinson's disease
Samantaray, S., Knaryan, V. H., Shields, D. C., & Banik, N. L. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12374 · Cited by 42
Lan, Y., Wang, X., Zou, Y., Xing, J., Lou, J., Zou, S., Ma, B., Ding, Y. P., & Zhang, B. (2019) · Inflammation Research · doi:10.1007/s00011-019-01217-z · Cited by 41
Yang, C.-C., Hsiao, L., Tseng, H., Kuo, C.-M., & Yang, C. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s252659 · Cited by 42
Łukaszewicz‐Zając, M., Mroczko, B., & Słowik, A. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1205-3 · Cited by 45
Stefano, M. E. D., & Herrero, M. T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.08.002 · Cited by 42
Mixed dementia: Neglected clinical entity or nosographic artifice?
Fierini, F. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.116662 · Cited by 46
Ten years of proteomics in multiple sclerosis
Farias, A. S., Pradella, F., Schmitt, A., Santos, L. M. B., & Martins‐de‐Souza, D. (2014) · PROTEOMICS · doi:10.1002/pmic.201300268 · Cited by 40
Abe, K., Chiba, Y., Hattori, S., Yoshimi, A., Asami, T., Katsuse, O., Suda, A., & Hishimoto, A. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116989 · Cited by 41
Role of Rho kinase in lysophosphatidic acid-induced altering of blood-brain barrier permeability
Yu, Y., Qin, J., Liu, M., RUAN, Q., Li, Y., & Zhang, Z. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1618 · Cited by 40
Catanzaro, V., Gringeri, C. V., Menchise, V., Padovan, S., Boffa, C., Dastrù, W., Chaabane, L., Digilio, G., & Aime, S. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209286 · Cited by 40
Vascular Dementia: From Pathophysiology to Therapeutic Frontiers
Yang, H. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14186611 · Cited by 48
Hainard, A., Tiberti, N., Robin, X., Ngoyi, D. M., Matovu, E., Enyaru, J., Müller, M., Turck, N., Ndung’u, J. M., Lejon, V., et al. (2010) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2010.02642.x · Cited by 39
Lanz, J., & Riedl, R. (2014) · ChemMedChem · doi:10.1002/cmdc.201402478 · Cited by 38
Ricci, S., Grandgirard, D., Wenzel, M., Braccini, T., Salvatore, P., Oggioni, M. R., Leib, S. L., & Koedel, U. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0726-6 · Cited by 40
Zhang, L., Postina, R., & Wang, Y. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0121-4 · Cited by 40
Recent insights into natural product inhibitors of matrix metalloproteinases
Kumar, G. B., Nair, B. G., Perry, J. J. P., & Martin, D. B. C. (2019) · MedChemComm · doi:10.1039/c9md00165d · Cited by 39
Soto-Rojas, L. O., Campa-Córdoba, B. B., Harrington, C. R., Salas‐Casas, A., Hernándes‐Alejandro, M., Villanueva‐Fierro, I., Bravo-Muñoz, M., Garcés‐Ramírez, L., de la Cruz‐López, F., Ontiveros‐Torres, M. Á., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073654 · Cited by 41
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia
Maetzler, W., Deleersnijder, W., Hanssens, V., Bernard, A., Brockmann, K., Marquetand, J., Wurster, I., Rattay, T. W., Roncoroni, L., Schaeffer, E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149349 · Cited by 36
Yıldız, M. O., Çelik, H., Çağlayan, C., Genç, A., Doğan, T., & Satıcı, E. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00945-2 · Cited by 39
Immune response and pathogen invasion at the choroid plexus in the onset of cerebral toxoplasmosis
Figueiredo, C. A., Steffen, J., Morton, L., Arumugam, S., Liesenfeld, O., Deli, M. A., Kröger, A., Schüler, T., & Dunay, I. R. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02370-1 · Cited by 37
Lemmens, K., Bollaerts, I., Bhumika, S., Groef, L. D., houcke, J. V., Darras, V., Hove, I. V., & Moons, L. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23920 · Cited by 38
Gonçalves, F. M., Martins-Oliveira, A., Lacchini, R., Belo, V. D. A., Speciali, J. G., Dach, F., & Tanus-Santos, J. E. (2012) · Gene · doi:10.1016/j.gene.2012.09.109 · Cited by 38
Latronico, T., Branà, M. T., Merra, E., Fasano, A., Bari, G. D., Casalino, E., & Liuzzi, G. M. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft146 · Cited by 38
MMP-3 Deficiency Alleviates Endotoxin-Induced Acute Inflammation in the Posterior Eye Segment
Hove, I. V., Lefevere, E., Groef, L. D., Sergeys, J., Salinas‐Navarro, M., Libert, C., Vandenbroucke, R. E., & Moons, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111825 · Cited by 37
Yang, C.-C., Lin, C.-C., Hsiao, L.-D., Kuo, J., Tseng, H., & Yang, C.-M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010259 · Cited by 35
Rosenberg, G. A., Prestopnik, J., Adair, J. C., Huisa, B. N., Knoefel, J. E., Caprihan, A., Gasparovic, C., Thompson, J. F., Erhardt, E. B., & Schrader, R. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309421 · Cited by 39
Self-citationTRIF-Mediated TLR3 and TLR4 Signaling Is Negatively Regulated by ADAM15
Ahmed, S., Maratha, A., Butt, A. Q., Shevlin, E., & Miggin, S. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201630 · Cited by 38
Metal complexes and metalloproteases: targeting conformational diseases
Grasso, G., & Bonnet, S. A. (2014) · Metallomics · doi:10.1039/c4mt00076e · Cited by 37
Jadavji, N. M., Farr, T. D., Lips, J., Khalil, A. A., Boehm‐Sturm, P., Foddis, M., Harms, C., Füchtemeier, M., & Dirnagl, U. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.01.040 · Cited by 36
Zhao, D., Li, Q., Liu, M., Ma, W., Zhou, T., Xue, C., & Cai, X. (2018) · Cell Proliferation · doi:10.1111/cpr.12442 · Cited by 37
Strain differences in the effects of chronic corticosterone exposure in the hippocampus
Hodes, G. E., Brookshire, B. R., Hill‐Smith, T. E., Teegarden, S. L., Berton, O., & Lucki, I. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.06.017 · Cited by 37
Matrix Metalloproteinase-8 is a Novel Pathogenetic Factor in Focal Cerebral Ischemia
Han, J. E., Lee, E., Moon, E., Ryu, J. H., Choi, J. W., & Kim, H.-S. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8996-y · Cited by 36
Sex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity
Tsiknia, A. A., Sundermann, E. E., Reas, E. T., Edland, S. D., Brewer, J. B., Galasko, D. R., Banks, S. J., & Initiative, A. D. N. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01106-4 · Cited by 39
Yonezawa, T., Hattori, S., Inagaki, J., Kurosaki, M., Takigawa, T., Hirohata, S., Miyoshi, T., & Ninomiya, Y. (2010) · Glia · doi:10.1002/glia.20959 · Cited by 36
Interactions between the extracellular matrix and inflammation during viral myocarditis
Papageorgiou, A., & Heymans, S. R. B. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.07.011 · Cited by 36
Mechanotransduction: Exploring New Therapeutic Avenues in Central Nervous System Pathology
Rocha, D. N., Carvalho, E. D., Relvas, J. B., Oliveira, M. J., & Pêgo, A. P. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.861613 · Cited by 41
Miao, M. Z., Su, Q. P., Cui, Y., Bahnson, E. M., Li, G., Wang, M., Yang, Y., Collins, J. A., Wu, D., Gu, Q., et al. (2023) · Science Signaling · doi:10.1126/scisignal.adf8299 · Cited by 37
Gough, M., Parr-Sturgess, C. A., & Parkin, E. T. (2010) · Biochemistry Research International · doi:10.1155/2011/721463 · Cited by 37
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells
Juknat, A., Rimmerman, N., Levy, R., Vogel, Z., & Kozela, E. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.12.002 · Cited by 35
Wang, X., Baokun, Z., Chen, Z., Qiang, S., Yang, E., Jianguang, X., & Xiaofeng, L. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.01.056 · Cited by 34
Protease detection in the biosensor era: A review
Rai, P., Hoba, S. N., Buchmann, C., Subirana-Slotos, R. J., Kersten, C., Schirmeister, T., Endres, K., Bufe, B., & Tarasov, A. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115788 · Cited by 37
Costa, A. C., Madsen, H., & Brown, J. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-45129-8 · Cited by 36
Palus, M., Žampachová, E., Elsterová, J., & Růžek, D. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.09.028 · Cited by 34
Tejeda, G. S., Ayuso‐Dolado, S., Arbeteta, R., Esteban-Ortega, G. M., Vidaurre, Ó. G., & Díaz‐Guerra, M. (2015) · The Journal of Pathology · doi:10.1002/path.4684 · Cited by 34
Mahajan, S. D., Aalinkeel, R., Reynolds, J. L., Nair, B. B., Sykes, D. E., Bonoiu, A. C., Roy, I., Yong, K., Law, W., Bergey, E. J., et al. (2011) · Immunological Investigations · doi:10.3109/08820139.2011.604863 · Cited by 32
Leukoaraiosis as an outcome predictor in the acute and subacute phases of stroke
Fierini, F., Poggesi, A., & Pantoni, L. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1371013 · Cited by 33
A systematic review on potential mechanisms of minocycline in kidney diseases
Haghi‐Aminjan, H., Asghari, M. H., Goharbari, M. H., & Abdollahi, M. R. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.02.001 · Cited by 32
Pérez‐Hernández, M., Fernández-Valle, M. E., Rubio‐Araiz, A., Vidal, R., Gutiérrez‐López, M. D., O’Shea, E., & Colado, M. I. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.03.019 · Cited by 33
The MMP-2/TIMP-2 System in Alzheimer Disease
Wang, H., Huang, L., Wu, L., Lan, J., Feng, X., Li, P., & Peng, Y. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200812223007 · Cited by 32
McKenna, M., Shackelford, D. B., Pontes, C., Ball, B. K., Gao, T., & Nance, E. A. (2021) · ACS Nano · doi:10.1021/acsnano.1c00394 · Cited by 32
Liu, X., Gao, J., Liu, S., Cheng, Y., Hao, L., Liu, S., & Zhu, W. (2022) · Animal nutrition · doi:10.1016/j.aninu.2022.09.011 · Cited by 36
MMPs: a novel drug target for schizophrenia
Chopra, K., Baveja, A., & Kuhad, A. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.957672 · Cited by 32
Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview
Javaid, M. A., Abdallah, M., Ahmed, A. S., & Sheikh, Z. (2013) · Acta Neurologica Belgica · doi:10.1007/s13760-013-0239-x · Cited by 32
Metalloproteinase alterations in the bone marrow of ALS patients
Bossolasco, P., Cova, L., Calzarossa, C., Servida, F., Mencacci, N. E., Onida, F., Polli, E. E., Deliliers, G. L., & Silani, V. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0584-7 · Cited by 32
Metalloproteinases and Metalloproteinase Inhibitors in Age-Related Diseases
Gargiulo, S., Gamba, P., Poli, G., & Leonarduzzi, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660701 · Cited by 34
Hawkins, K. E., DeMars, K. M., Yang, C., Rosenberg, G. A., & Candelario‐Jalil, E. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-14 · Cited by 31
Self-citationOlsen, I., & Singhrao, S. K. (2020) · Journal of Oral Microbiology · doi:10.1080/20002297.2020.1820834 · Cited by 34
Thrombospondin‐4 promotes bladder cancer cell migration and invasion via MMP2 production
Chou, K., Chang, A., Ho, C., Tsai, T., Chen, H., Chen, P., & Hwang, T. I. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16463 · Cited by 30
Matrix Metalloproteinases and Glaucoma
Kim, M. H., & Lim, S. (2022) · Biomolecules · doi:10.3390/biom12101368 · Cited by 31
Wu, J., Yang, J., Lu, X., Jin, C., Wu, S., Zhang, L., Hu, X., Ma, H., & Cai, Y. (2018) · Biological Trace Element Research · doi:10.1007/s12011-018-1402-2 · Cited by 33
The neurovascular unit in healthy and injured spinal cord
Zhou, R., Li, J., Wang, R., Chen, Z., & Zhou, F. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231172008 · Cited by 31
Ryang, Y.-M., Dang, J., Kipp, M., Petersen, K.-U., Fahlenkamp, A. V., Gempt, J., Wesp, D., Rossaint, R., Beyer, C., & Coburn, M. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-113 · Cited by 30
Lin, H., Chen, Y., Wang, K., Chien, H., Hsieh, Y., & Yang, S. (2017) · PubMed Central · Cited by 30
Increased MMP-3 and CTGF expression during lipopolysaccharide-induced dopaminergic neurodegeneration
McClain, J. A., Phillips, L. L., & Fillmore, H. L. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.05.044 · Cited by 30
TIMP-1 Protects Tight Junctions of Brain Endothelial Cells From MMP-Mediated Degradation
Ahmadighadykolaei, H., Lambert, J. A., & Raeeszadeh‐Sarmazdeh, M. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03593-y · Cited by 30
The mechanics of the retina: Müller glia role on retinal extracellular matrix and modelling
Prieto-López, L., Pereiro, X., & Vecino, E. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1393057 · Cited by 37
Xu, F., Sun, S., Ho, A. S.-W., Lee, D. P. H., Kiang, K. M. Y., Zhang, X., Wang, A. M., Wu, E. X., Lui, W., Liu, B., et al. (2014) · Brain Injury · doi:10.3109/02699052.2014.943289 · Cited by 29
Groef, L. D., Andries, L., Lemmens, K., Hove, I. V., & Moons, L. (2015) · BMC Ophthalmology · doi:10.1186/s12886-015-0176-y · Cited by 29
Serum metalloproteinase 9 levels increase after generalized tonic-clonic seizures
Cudna, A., Jopowicz, A., Mierzejewski, P., & Kurkowska‐Jastrzębska, I. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.11.006 · Cited by 30
Rizzo, F., Ramirez, A., Compagnucci, C., Salani, S., Melzi, V., Bordoni, A., Fortunato, F., Niceforo, A., Bresolin, N., Comi, G. P., et al. (2017) · Scientific Reports · doi:10.1038/srep46271 · Cited by 29
Plasma proteome in multiple sclerosis disease progression
Malekzadeh, A., Leurs, C. E., van Wieringen, W. N., Steenwijk, M. D., Schoonheim, M. M., Amann, M., Naegelin, Y., Kühle, J., Killestein, J., & Teunissen, C. E. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.771 · Cited by 29
CSF MicroRNAs Reveal Impairment of Angiogenesis and Autophagy in Parkinson Disease
Fowler, A. J., Ahn, J., Hebron, M., Chiu, T., Ayoub, R., Mulki, S., Ressom, H., Torres-Yaghi, Y., Wilmarth, B., Pagan, F. L., et al. (2021) · Neurology Genetics · doi:10.1212/nxg.0000000000000633 · Cited by 29
Trentini, A., Manfrinato, M. C., Castellazzi, M., & Bellini, T. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081196 · Cited by 30
Jeon, S., Chun, S., Choi‐Kwon, S., Chi, H., Nah, H., Kwon, S. U., Kim, W.-K., & Kim, J. S. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.04.013 · Cited by 29
Schiffmann, S., Weigert, A., Männich, J., Eberle, M., Birod, K., Häußler, A., Ferreirós, N., Schreiber, Y., Kunkel, H., Grez, M., et al. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.006 · Cited by 29
Deretzi, G., Kountouras, J., Grigoriadis, N., Zavos, C., Chatzigeorgiou, S., Koutlas, E., & Tsiptsios, I. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.04.021 · Cited by 29
Matrix metalloproteinases and epileptogenesis
Ikonomidou, C. (2014) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-014-0006-y · Cited by 28
Matrix Metalloproteinases During Axonal Regeneration, a Multifactorial Role from Start to Finish
Andries, L., Hove, I. V., Moons, L., & Groef, L. D. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9801-x · Cited by 27
Hoeksema, M. A., Laan, L. C., Postma, J. J., Cummings, R. D., de Winther, M. P. J., Dijkstra, C. D., van Die, I., & Kooij, G. (2016) · The FASEB Journal · doi:10.1096/fj.201600343r · Cited by 27
Agarwal, S., Muniyandi, P., Maekawa, T., & Kumar, D. S. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.033 · Cited by 27
Carnosine Protects against Cerebral Ischemic Injury by Inhibiting Matrix-Metalloproteinases
Kim, E.-H., Kim, E. S., Shin, D., Kim, D., Choi, S., Shin, Y., Kim, K.-A., Noh, D., Çağlayan, A. B., Rajanikant, G. K., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147495 · Cited by 28
Metalloproteinases and their inhibitors in neurological disease
Lopez-Navarro, E. R., & Gutierrez, J. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02188-x · Cited by 26
Dąbrowski, W., Rzecki, Z., Czajkowski, M., Piłat, J., Wacinski, P. J., Kotlińska-Hasiec, E., Sztanke, M., Sztanke, K., Stążka, K., & Pasternak, K. (2011) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2011.10.014 · Cited by 28
Huang, Z., Yin, Q., Sun, W., Zhu, W., Li, Y., Liu, W., Xiao, L., Duan, Z., Cai, Q., Liu, D., et al. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.07.2513 · Cited by 28
Trentini, A., Manfrinato, M. C., Castellazzi, M., Tamborino, C., Roversi, G., Volta, C. A., Baldi, E., Tola, M. R., Granieri, E., Dallocchio, F., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514560925 · Cited by 29
Implication of matrix metalloproteinases in regulating neuronal disorder
Mukherjee, A. K., & Swarnakar, S. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3752-y · Cited by 27
Tomasik, J., Schwarz, E., Lago, S. G., Rothermundt, M., Leweke, F. M., van Beveren, N. J. M., Guest, P. C., Rahmoune, H., Steiner, J. H., & Bahn, S. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.10.019 · Cited by 27
El‐Sayed, N. F., El‐Hussieny, M., Ewies, E. F., Fouad, M. A., & Boulos, L. S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103499 · Cited by 27
Brain organoids for hypoxic-ischemic studies: from bench to bedside
Gaston-Breton, R., Maïza, A., Hamoudi, R., Stonestreet, B. S., & Mabondzo, A. M. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04951-0 · Cited by 29
Rubio‐Araiz, A., Pérez‐Hernández, M., Urrutia, A. A., Porcu, F., Borcel, É., Gutiérrez‐López, M. D., O’Shea, E., & Colado, M. I. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000145 · Cited by 27
Rosenberg, G. A. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0277-4 · Cited by 27
Self-citationMatrix Metalloproteinase-9 Expression in Calcified Human Aortic Valves
Perrotta, I. D., Sciangula, A., Aquila, S., & Mazzulla, S. (2014) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000144 · Cited by 27
Metadata
- Authors
- Rosenberg, G. A.
- Affiliations
- University of New Mexico (US)
- Corresponding author
- Rosenberg, Gary A
- ORCID
- Rosenberg, Gary A
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 8
- Issue
- 2
- Pages
- 205-216
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W2124054487
- Cited by
- 594
- References
- 107
- Citations by year
- 2026: 27 · 2025: 23 · 2024: 18 · 2023: 34 · 2022: 33 · 2021: 35 · 2020: 29 · 2019: 28 · 2018: 22 · 2017: 34 · 2016: 33 · 2015: 52 · 2014: 54 · 2013: 47 · 2012: 37
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS045847, R01NS052305)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- matrix metalloproteinases, ADAMS, neuroinflammation, neurodegenerative diseases, blood-brain barrier permeability, tissue inhibitors of metalloproteinases, matrix metalloproteinase inhibitors, Alzheimer's disease, amyloid, Parkinson's disease, dopaminergic neurons, vascular cognitive impairment, white matter injury, angiogenesis, neurogenesis, signal transduction
- MeSH terms
- Humans, Inflammation, Protease Inhibitors, Neurodegenerative Diseases, Matrix Metalloproteinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review